Over 30% Jump In FDA Warning Letters To Non-US Device Firms
This article was originally published in Clinica
The number of US FDA quality-related warning letters sent to foreign device manufacturers is on the rise, recent agency data shows.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.